CAD 0.06
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.76 Million CAD | -64.42% |
2022 | 3.53 Million CAD | -14.55% |
2021 | 4.14 Million CAD | -29.15% |
2020 | 5.84 Million CAD | -20.06% |
2019 | 7.31 Million CAD | 253.39% |
2018 | 2.06 Million CAD | 1524.88% |
2017 | 127.3 Thousand CAD | 875.22% |
2016 | 13.05 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 1.18 Million CAD | 126.37% |
2024 Q2 | 390.66 Thousand CAD | -19.33% |
2024 Q1 | 484.26 Thousand CAD | -5.81% |
2023 Q2 | 465.51 Thousand CAD | 2.61% |
2023 Q1 | 453.69 Thousand CAD | -40.12% |
2023 FY | 1.25 Million CAD | -64.42% |
2023 Q4 | 514.14 Thousand CAD | 97.07% |
2023 Q3 | 260.89 Thousand CAD | -43.96% |
2022 Q4 | 757.71 Thousand CAD | -12.8% |
2022 Q3 | 868.95 Thousand CAD | -4.49% |
2022 Q2 | 909.81 Thousand CAD | -9.16% |
2022 Q1 | 1 Million CAD | -26.23% |
2022 FY | 3.53 Million CAD | -14.55% |
2021 FY | 4.14 Million CAD | -29.15% |
2021 Q2 | 751.52 Thousand CAD | -21.53% |
2021 Q3 | 729.35 Thousand CAD | -2.95% |
2021 Q4 | 1.35 Million CAD | 86.15% |
2021 Q1 | 957.73 Thousand CAD | -36.05% |
2020 Q4 | 1.49 Million CAD | 27.72% |
2020 Q1 | 1.7 Million CAD | 162.94% |
2020 Q2 | 1.47 Million CAD | -13.64% |
2020 FY | 5.84 Million CAD | -20.06% |
2020 Q3 | 1.17 Million CAD | -20.28% |
2019 Q3 | 1.58 Million CAD | -62.56% |
2019 FY | 7.31 Million CAD | 253.39% |
2019 Q4 | 647.72 Thousand CAD | -59.07% |
2019 Q2 | 4.22 Million CAD | 8727.54% |
2019 Q1 | 47.88 Thousand CAD | 49.21% |
2018 Q1 | 21.02 Thousand CAD | -52.0% |
2018 Q2 | 82.11 Thousand CAD | 290.57% |
2018 FY | 2.06 Million CAD | 1524.88% |
2018 Q3 | 13.89 Thousand CAD | -83.08% |
2018 Q4 | 32.09 Thousand CAD | 131.07% |
2017 FY | 127.3 Thousand CAD | 875.22% |
2017 Q3 | 22.8 Thousand CAD | 0.0% |
2017 Q4 | 43.8 Thousand CAD | 92.08% |
2016 FY | 13.05 Thousand CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aion Therapeutic Inc. | 163.11 Thousand CAD | -983.891% |
Ayurcann Holdings Corp. | 11.71 Million CAD | 84.91% |
Blueberries Medical Corp. | 84.22 Thousand CAD | -1999.151% |
The BC Bud Corporation | 1.28 Million CAD | -37.805% |
BioNxt Solutions Inc. | 6.73 Million CAD | 73.767% |
CordovaCann Corp. | 3.86 Million CAD | 54.216% |
Christina Lake Cannabis Corp. | 4.28 Million CAD | 58.722% |
Captor Capital Corp. | 16.28 Million CAD | 89.142% |
City View Green Holdings Inc. | 705.7 Thousand CAD | -150.53% |
1CM Inc. | 7.3 Million CAD | 75.807% |
Global Hemp Group Inc. | 551.7 Thousand CAD | -220.461% |
Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | 63.225% |
IM Cannabis Corp. | 22.63 Million CAD | 92.19% |
Lobe Sciences Ltd. | 4.13 Million CAD | 57.214% |
Maple Leaf Green World Inc. | 392.21 Thousand CAD | -350.775% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -2846.683% |
Ovation Science Inc. | 54.1 Thousand CAD | -3168.041% |
Pharmadrug Inc. | 1.33 Million CAD | -32.434% |
Captiva Verde Wellness Corp. | 1.3 Million CAD | -35.437% |
RAMM Pharma Corp. | 7.48 Million CAD | 76.365% |
RIV Capital Inc. | 21.1 Million CAD | 91.622% |
Revive Therapeutics Ltd. | 3.28 Million CAD | 46.191% |
Red White & Bloom Brands Inc. | 37.75 Million CAD | 95.318% |
SLANG Worldwide Inc. | 24.6 Million CAD | 92.815% |
1933 Industries Inc. | 5.12 Million CAD | 65.504% |
Red Light Holland Corp. | 2.02 Million CAD | 12.495% |
Top Strike Resources Corp. | 3.63 Million CAD | 51.318% |
Xebra Brands Ltd. | -308.42 Thousand CAD | 673.244% |
Adastra Holdings Ltd. | 9.36 Million CAD | 81.112% |